A common gut antibody may prevent colon cancer before it starts
Reported bySciTechDaily ↗·Sourced by Goodlede
Researchers at Rockefeller University found that mice lacking immunoglobulin A (IgA) developed more than twice as many colon tumors as normal mice, and oral IgA eliminated their increased cancer risk, potentially explaining why people with IgA deficiency face higher colorectal cancer risk.
Tested in mice. Human prevention strategies have not yet been developed or tested.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at SciTechDaily
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede